|
Valiant Laboratories Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
471.76 Cr.
|
P/BV
|
1.49
|
Book Value (Rs.)
|
58.14
|
|
52 Week High/Low (Rs.)
|
119/75
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
19/07/2025
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 |
| | | | |
| | | | |
| INCOME | | | |
| Revenue From Operations [Net] | 130.38 | 180.19 | 332.11 |
| Other Operating Revenues | 3.00 | 1.87 | 1.80 |
| Total Operating Revenues | 133.38 | 182.06 | 333.91 |
| | | | |
| Other Income | 5.43 | 9.68 | 4.86 |
| Total Revenue | 138.82 | 191.74 | 338.77 |
| | | | |
| EXPENSES | | | |
| Cost Of Materials Consumed | 112.18 | 169.39 | 277.28 |
| Purchase Of Stock-In Trade | 0.56 | 0.00 | 0.28 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 3.86 | -1.14 | -0.24 |
| Employee Benefit Expenses | 4.39 | 4.31 | 4.61 |
| Finance Costs | 0.18 | 0.08 | 0.25 |
| Depreciation And Amortisation Expenses | 2.09 | 1.97 | 1.56 |
| Other Expenses | 17.07 | 17.90 | 16.89 |
| Total Expenses | 140.33 | 192.51 | 300.64 |
| | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -1.51 | -0.77 | 38.14 |
| | | | |
| Profit/Loss Before Tax | -1.51 | -0.77 | 38.14 |
| | | | |
| Tax Expenses-Continued Operations | | | |
| Current Tax | 0.06 | -0.98 | 8.80 |
| Deferred Tax | 0.63 | -0.11 | 0.34 |
| Total Tax Expenses | 0.69 | -1.09 | 9.14 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -2.20 | 0.32 | 29.00 |
| | | | |
| Profit/Loss From Continuing Operations | -2.20 | 0.32 | 29.00 |
| | | | |
| Profit/Loss For The Period | -2.20 | 0.32 | 29.00 |
| Consolidated Profit/Loss After MI And Associates | -2.20 | 0.32 | 29.00 |
| | | | |
| OTHER INFORMATION | | | |
| | | | |
| EARNINGS PER SHARE | | | |
| Basic EPS (Rs.) | -0.51 | 0.13 | 8.91 |
| Diluted EPS (Rs.) | -0.51 | 0.13 | 8.91 |
